← All trials
NCT05472311
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 17, 2022
- Primary completion
- Apr 26, 2026
- Completion date
- Nov 30, 2026
- First posted
- Jul 25, 2022
- Last posted
- Nov 7, 2022
- Enrollment
- 565
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of WashingtonLead sponsor
- National Cancer Institute (NCI)Collaborator
- University of WashingtonOverall official - principal investigator
- University of WashingtonReponsible party - principal investigator
- Kenya Medical Research InstituteCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.